Daledalin tosylate

• UNSPSC Description:

  Daledalin tosylate (UK 3557) has mono-amine oxidase inhibitory activity in vitro, probably by acting as a substrate. Daledalin tosylate also has antidepressant effects. Daledalin tosylate potentiates amphetamine-induced excitation in rats, antagonises Reserpine (HY-N0480)-hypothermia in mice, tetrabenazine-sedation in rats and Reserpine (HY-N0480)- and Tetrabenazine (HY-B0590)-induced ptosis in mice with . Daledalin tosylate is proming for rasearch of depressive illness[1].

• Target Antigen:

  Monoamine Oxidase

• Type:

  Reference compound

• Related Pathways:

  Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/daledalin-tosylate.html

• Smiles:

  CC1(CCCNC)CN(C2=CC=CC=C2)C3=C1C=CC=C3.O=S(C4=CC=C(C)C=C4)(O)=O

• Molecular Weight:

  452.61

• References & Citations:

  [1]Edwards JG, et al. Daledalin tosylate: a controlled trial in depressive illness. Curr Med Res Opin. 1974;2(6):305-12.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  23226-37-1